Guidance Sets Out How Notified Bodies Must Assess Highest Risk IVDs Under New Regulation
The highest risk IVDs, which fall into class D, are subject to additional testing criteria. New guidance explains how the notified body acts − not only as reviewer but also as facilitator so additional safety and performance guarantees can be sought.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-six documents have been posted on the tracker since its last update.
Work related to the European Commission’s promise to assess the impact of the Medical Device Regulation, including its impact on innovation, is starting to take shape.
Medtech developers have just over a month to apply for the pilot phase of a program offering regulatory and practical support to accelerate innovative product access to the UK NHS.